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The histone demethylase JMJD2A/KDM4A links
ribosomal RNA transcription to nutrients and
growth factors availability
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Konstantin I. Panov3,4,** & Marie Vandromme1,2,**
The interplay between methylation and demethylation of histone lysine residues is an
essential component of gene expression regulation and there is considerable interest in
elucidating the roles of proteins involved. Here we report that histone demethylase KDM4A/
JMJD2A, which is involved in the regulation of cell proliferation and is overexpressed in some
cancers, interacts with RNA Polymerase I, associates with active ribosomal RNA genes and is
required for serum-induced activation of rDNA transcription. We propose that KDM4A
controls the initial stages of transition from ‘poised’, non-transcribed rDNA chromatin into its
active form. We show that PI3K, a major signalling transducer central for cell proliferation and
survival, controls cellular localization of KDM4A and consequently its association with
ribosomal DNA through the SGK1 downstream kinase. We propose that the interplay
between PI3K/SGK1 signalling cascade and KDM4A constitutes a mechanism by which cells
adapt ribosome biogenesis level to the availability of growth factors and nutrients.
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E
ukaryotic genomic DNA, in a complex with histone
proteins, is organized into a densely packed DNA–protein
complex called chromatin, which harbours different
levels of structural complexity and hierarchy1. Chromatin
structure regulates DNA accessibility and therefore modulates
the activity of enzymatic complexes requiring access to DNA.
These complexes are involved in major cellular processes
such as transcription, replication and DNA repair. Chromatin
architecture is dynamic and regulated by DNA methylation2,
chromatin remodelers3 and various histone modiﬁcations4. These
epigenetic modiﬁcations play crucial roles in determining cell fate
and the cellular response to external and internal stimuli.
The basic unit of chromatin is the nucleosome composed of
146 bp of DNA wrapped around an octamer of histones (two
copies of each histone H2A, H2B, H3 and H4). Post-translational
modiﬁcations of histones such as acetylation, phosphorylation or
methylation are central in the regulation of chromatin structure.
Histone modiﬁcations are reversible through the action
of enzymes carrying antagonist activities. One of the key
components of epigenetic regulation of transcription is the
balance between methylation and demethylation of lysine
residues in histones. Enzymes methylating lysines (lysine methyl
transferases, KMTs) and enzymes removing methyl groups from
lysines (histone demethylases, KDMs) are highly speciﬁc for given
lysine residues. Many lysine residues in histones H3 and H4 can
be mono- (me), di- (me2) or trimethylated (me3), including
lysine 9 (K9), lysine 36 (K36) and lysine 4 (K4) on H3. H3K9
methylation is enriched in heterochromatin and is associated with
the promoters of repressed genes in euchromatin. By contrast,
methylation of H3K4 at the promoter, or H3K36 in the coding
region mark active genes in euchromatin.
Ribosomal DNA (rDNA) encodes the 47S precursor of the 28S,
18S and 5S ribosomal RNA (rRNA) that are the main
RNA components of ribosomes. Transcription of rRNA genes
by RNA Polymerase I (Pol-I) is a key stage of ribosome biogenesis
is directly linked to cell growth and proliferation and is regulated
by a variety of signalling cascades including PI3K, mTOR and
MAPK pathways5,6. Eukaryotic genomes contain a large
number of rDNA repeats (in humans B350 copies) described
to exist in three distinct chromatin states: epigenetically silenced
heterochromatin which is maintained throughout the life of a
cell, and two different forms of transcriptionally competent
euchromatin: non-transcribed, ‘closed’ chromatin and actively
transcribed ‘open’ chromatin7,8. The currently accepted model of
rDNA transcription regulation in higher eukaryotes suggests
that the number of epigenetically silenced rDNA genes is
maintained during a normal cell cycle, but it can be modiﬁed
during development, differentiation and disease9,10. The
euchromatic rDNA copies are those subjected to transcriptional
regulation in response to routine variations in external conditions
(for example, nutrients, growth factors, stresses), to link
rRNA synthesis to environmental conditions. The efﬁciency
of rRNA synthesis at these ‘euchromatic’ copies is regulated
by a combination of two non-exclusive mechanisms: through
the alteration of the rate of transcription and of Pol-I density
and through epigenetic mechanisms that allow the passage
from the closed to open chromatin states, such as post-
translational modiﬁcations of histones and the re-positioning of
nucleosomes8,11,12. However, how chromatin architecture is
controlled by growth factors/nutrients is still poorly understood
despite continued efforts.
In this manuscript, we report the involvement of the histone
demethylase KDM4A in the regulation of rDNA transcription. As
a member of the KDM4 family, KDM4A (also called JMJD2A
or JHDM3A) is speciﬁc for H3K9me2/3 and H3K36me2/3
(refs 13,14). Previous studies showed that KDM4A inﬂuences
cell cycle progression and cell proliferation either through
transcriptional control of key regulators of the cell cycle or
by regulating replication timing15,16. Interestingly, it was
recently shown that KDM4A also regulates protein translation
in the cytosol17.
Here, we describe that KDM4A localizes within nucleoli,
interacts with Pol-I machinery, binds to rDNA promoter and
favours serum-stimulated rDNA transcription by demethylating
H3K9me3. Moreover, we show that KDM4A nucleolar
localization, and therefore its recruitment to chromatin, is
controlled by the PI3K–SGK1 pathway, which is activated by
growth factor/nutrients. Thus, our results demonstrate KDM4A
as a growth factor/nutrients-dependent regulator of rDNA
transcription, and highlight the key role of KDM4A in the
processes that regulate cell growth and proliferation.
Results
KDM4A is a nucleolar protein and associates with rDNA.
KDM4A subcellular localization was determined in growing
U2OS cells by indirect immunoﬂuorescence using an antibody
directed against the C-terminal part of KDM4A (anti-KDM4A-
Ab1, Fig. 1a). As expected, KDM4A was found in the nucleus.
Interestingly, inside the nucleus, the staining was not uniform
and we observed that darker zones of 40,60-diamindino-2-phe-
nylindole (DAPI) stained nuclear DNA, which correspond to
nucleoli, exhibited a brighter staining. Moreover, KDM4A
co-localized with the largest subunit of Pol-I (A194, Fig. 1a) and
other nucleolar proteins (ﬁbrillarin or UBF, a Pol-I transcription
factor (Supplementary Fig. 1a)). Importantly, a similar pattern
was also observed using a second antibody directed against the
N-terminal part of KDM4A (anti KDMA-Ab2, Supplementary
Fig. 1b), indicating that the signal is indeed speciﬁc to
KDM4A and not due to any cross-reaction with another protein.
Note that this nucleolar localization was observed both by
classical immunoﬂuorescence (Supplementary Fig. 1b), or
following extraction of soluble proteins by triton treatment before
ﬁxation (Fig. 1a and Supplementary Fig. 1a), indicating that
KDM4A is tightly bound inside the nucleolus.
Similar results were observed in other cells, such as
transformed cell lines (HeLa, GC92) or primary ﬁbroblasts
(WI38; Supplementary Fig. 2a). Noticeably, by contrast to
KDM4A, the histone demethylase LSD1 was excluded from the
nucleolus of U2OS cells (Supplementary Fig. 2b), indicating that
nucleoli accumulation is not a general feature of KDMs.
Nucleoli are the sites of rDNA transcription driven by RNA
Pol-I. rDNA genes, which encode the 47S rRNA precursor are
present in multiple copies in the human genome (4300 copies)
and localize inside the nucleoli during interphase. Considering
that KDM4A is a chromatin modiﬁer, we next tested its
association with rDNA. We performed chromatin immunopre-
cipitation (ChIP) experiments using chromatin from growing
U2OS cells and analysed KDM4A occupancy at various regions
from the rDNA repeats by quantitative PCR (qPCR; Fig. 1b,c). To
present speciﬁc changes at transcribed (TrR) and non-transcribed
(nTrR) regions of rDNA, we averaged signals from four
amplicons in TrR and from two in nTrR (Fig. 1b). Values
obtained using the different probes along the transcribed (or non-
transcribed) region were generally very similar (see for example
Supplementary Fig. 9).
We observed a strong enrichment of rDNA promoter regions in
ChIPs performed using two different KDM4A-speciﬁc antibodies,
and a low enrichment of other rDNA regions (transcribed,
terminator and intergenic regions, (Fig. 1c, see Supplementary
Fig. 3a for raw data), indicating that KDM4A is speciﬁcally
associated with the rDNA promoter in growing U2OS cells.
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This speciﬁc association led us to test whether KDM4A
can interact with the Pol-I transcription machinery. We
immunoprecipitated endogenous KDM4A from U2OS nuclear
extracts and analysed immunoprecipitated complex by Western
blotting using antibodies speciﬁc to the large subunit of Pol-I
A194, Pol-I speciﬁc transcription factor UBF and two subunits of
Pol-I promoter recognition factor SL1 (TAFI110 and TAFI63).
We found that Pol-I, but not UBF or SL1, co-precipitated with
KDM4A, demonstrating that endogenous KDM4A and Pol-I are
present within the same multimolecular complex (Fig. 1d).
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Figure 1 | KDM4A is a nucleolar protein. (a) Actively growing U2OS cells (conﬂuency 60–70%) were ﬁxed following extraction with 1% Triton X-100 and
analysed by indirect immunoﬂuorescence using antibodies speciﬁc to human KDM4A (Ab1 Bethyl Lab, panel 1) and human Pol-I largest subunit A194
(panel 2); nuclear DNA was stained by DAPI (panel 3). Images were acquired with a Leica ﬂuorescent microscope (DM5000- 20 objective).
Representative nuclei are shown with associated merged images (panel 4). Scale bar, 5 mM. (b) A diagram of the human rDNA repeat is shown indicating
the positions of eight sets of speciﬁc PCR primer/probes used for qPCR analysis of immunoprecipitated DNA. 50ETS, 50-external transcribed spacer; IGS,
intergenic spacer; Prom, the rRNA promoter, term, the terminator. Signal representing the transcribed region (TrR) is the average of the combined signal
from 50ETS, 18S, 5.8S and 28S rRNA. Signal representing the non-transcribed region (nTrR) is the average of the combined signal from IGS1 and IGS2.
(c) ChIP assays were performed using antibodies speciﬁc to human KDM4A from two different sources and analysed by qPCR using eight sets of speciﬁc
probes and primers derived from different regions of rDNA repeats (see the diagram above). The value of each bar represents the difference between the
signals from the speciﬁc antibody and from the negative control (an appropriate IgG) expressed as % from total chromatin input (see Supplementary
Fig. 3a for raw data). Signal representing the transcribed region (TrR) is the average of the combined signal from 50ETS, 18S, 5.8S and 28S rRNA. Signal
representing the non-transcribed region (nTrR) is the average of the combined signal from IGS1 and IGS2. The s.d.’s from three independent experiments
are shown; n¼ 3. (d, e) KDM4A was immunoprecipitated from nuclear extract of U2OS cells using KMD4A-speciﬁc antibodies (Bethyl).
Immunoprecipitated complexes were analysed by western blotting using either antibodies speciﬁc to human Pol-I largest subunit A194 and UBF (lane 4), or
to SL1 subunits TAF1110 and TAF163 (lane 7). Input—lanes 1, 2 and 6, negative control (anti-HA antibodies)—lanes 3 and 8. Puriﬁed SL1—lane 5. Positions
of prestained molecular weight markers (PageRuler Plus, Fermentas) are indicated.
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Altogether, these results show that KDM4A is a nucleolar
protein that interacts with Pol-I and associates with the rDNA
promoter, suggesting that it may play a role in regulating rDNA
transcription.
KDM4A is dispensable for steady-state rRNA synthesis.
Because KDM4A is present at the rDNA promoter in growing
cells (Fig. 1c), we analysed its involvement in Pol-I transcription
in asynchronously growing cells. Neither siRNA-mediated
knockdown of KDMA4 (Fig. 2a,b) nor overexpression of a
demethylase defective mutant (Fig. 2d,e) (working as a dominant-
negative mutant in starved–refed conditions, see below) had
major effects on the level of rDNA transcription in growing
U2OS cells (Fig. 2b,e) or on U2OS cells proliferation (Fig. 2c).
Thus, although KDM4A is associated with rDNA promoter in
growing cells suggesting a potential role for this enzyme, it does
not seem to be important for efﬁcient rDNA transcription. We
cannot rule out the possibility that combination of low require-
ments for KDM4A in growing cell and o100% efﬁciency of
siRNA-mediated depletion and endogenous KDM4A inhibition
led to the apparent lack of the effects of KDM4A siRNA and
dominant-negative mutant overexpression in growing cells.
Nevertheless, these ﬁndings suggest that KDM4A is largely
dispensable for the maintenance of rDNA repeats transcription.
KDM4A is required for serum-induced rDNA transcription.
rDNA transcription is tightly regulated by the supply in growth
factors and nutrients that impact on the energy status of the cell
and regulate intracellular metabolites levels18. Serum contains
both growth factors and nutrients and, as a consequence, rRNA
production is repressed upon serum deprivation and re-activated
upon serum addition. This serum-dependent regulation of rDNA
transcription is associated with chromatin remodelling and
changes in histone modiﬁcations (for latest review see ref. 19).
We thus tested the effect of KDM4A depletion on de novo
rRNA synthesis in starved–refed cells. Serum-starved cells were
transfected with a siRNA directed against KDM4A or a non-
targeting siRNA as a control before stimulation by serum (see
Supplementary Fig. 4 for siRNA efﬁciency) and rRNA expression
was analysed by 3H-Uridine labelling at different times following
serum addition (Fig. 3a). As expected, the expression of pre-RNA
transcripts was activated following serum stimulation in control
cells. However, this activation was signiﬁcantly reduced in
KDM4A-depleted cells (Fig. 3b,c), demonstrating that KDM4A
is important for serum-induced activation of the pre-rRNA
production. A similar result was also observed when rRNA
expression was assessed in individual cells by metabolic labelling
with 5-Fluorouridine (5-FUrd; Fig. 3d–f). Notably, three different
siRNA were used in these experiments, ruling out any off-target
effects of siRNAs. Importantly, we found that KDM4A depletion
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Figure 2 | KDM4A is not essential for ongoing Pol-I transcription. (a) Schematic representation of the labelling of cells with 3H-uridine to determine the
effect of KDM4A depletion on ongoing rRNA synthesis. RNA was extracted 2 and 4 h after 3H-uridine addition and de novo rRNA transcripts were detected
by tritium imaging of RNA blots as in Fig. 3b. (b) The relative efﬁciencies of rRNA synthesis were quantitated as in Fig. 3 and transcript levels are indicated
for 47S/45S pre-rRNA. The data, expressed as a percentage of the highest value (set at 100%). The s.d.’s for three independent experiments are shown;
n¼ 3. (c) The relative efﬁciencies of cell growth were determined using MTTassay. The s.d.’s for four independent samples are shown; n¼4. (d) Growing
U2OS cells (B70% conﬂuent) were electroporated with an expression vector encoding either wild-type KDM4A (WT) or catalytically inactive mutant
(MUT). Cells were grown for 48 h and then 5-FUrd was added for 30min and cells were ﬁxed and analysed by indirect immunoﬂuorescence using
antibodies speciﬁc to 5-FUrd (anti-BrdU antibodies); nuclear DNA was stained by DAPI. (e) Box-and-whiskers plot of the quantiﬁcation of 5-FUrd staining
per cell (n¼ 100–200) obtained from the experiment shown in d using R open source software (a.u. stands for arbitrary units). Note that the 5-FUrd levels
of the cell populations overexpressing the MUTand the WTare not signiﬁcantly different (P value¼0.637, Wilcoxon test). The median values are shown as
horizontal lines, outliers are shown as open circles; n¼ 3.
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did not affect the expression of UBF and Pol-I (Supplementary
Fig. 4b) suggesting a direct role of KDM4A in the regulation of
rRNA synthesis.
All together, these results demonstrate that KDM4A is
speciﬁcally involved in the activation of Pol-I-driven transcription
in response to serum.
KDM4A behaviour is regulated by serum. We next analysed
KDM4A behaviour in starved and starved–refed cells. U2OS cells
were serum starved and refed with serum as in Fig. 3 and RNA
isolated from starved and refed cells were analysed by RT-qPCR
(Supplementary Fig. 5a). As expected, the levels of the pre-rRNA
increased following serum addition. However, no signiﬁcant
changes were observed in the mRNA levels of KDM4A, KDM4B
or KDM4C histone demethylases. At the protein level, we
observed a reproducible increase in KDM4A protein levels (by
approximately twofold) upon serum addition, which was due to
increased stability of KDM4A (Supplementary Fig. 5b,c).
We also analysed KDM4A cellular localization in starved and
starved–refed cells at two different time points after serum
addition. We found that in starved cells, KDM4A largely lost its
nucleolar localization, which was rapidly restored following
serum addition (Fig. 4a; Supplementary Fig. 7a,b), indicating
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Figure 3 | KDM4A is important for serum-induced rRNA synthesis. (a) Schematic representation of the labelling of cells with 3H-uridine to determine
the effect of KDM4A depletion on activation of rRNA synthesis. U2OS cells were transfected either with non-targeting (siScr) or KDM4A-speciﬁc siRNA3
(siA3). 24 h post-transfection cells were starved. Transcription was activated by addition of serum and 3H-uridine at time point 0. (b) RNA was extracted
15, 30, 60 and 90min after serum addition and de novo rRNA transcripts were detected by tritium imaging of RNA blots (top panel) using X-ray ﬁlm. Total
18S and 28S rRNAs were detected by ethidium bromide staining (bottom panel). (c) To determine the relative efﬁciencies of rRNA synthesis, RNA blots
were imaged using tritium image plate (Fuji) and quantitated with aid of phosphoimager (Fuji) and Aida software (Raytec). Transcript levels are indicated
for 47S/45S pre-rRNA. The data are expressed as a percentage of the highest value (set at 100%). The s.d.’s for three independent experiments are shown;
n¼ 3. (d). Schematic representation of the labelling of cells with 5-FUrd to determine the effect of KDM4A depletion on activation of rRNA synthesis in
individual cells. U2OS cells were serum-starved for 16 h, electroporated with either a non-targeting siRNA (siScr) or two siRNAs directed against KDM4A
(siA1 and siA2) and kept in serum-free medium for further 24 h before serum refeeding in the presence of 5-FUrd for 30min. (e). Cells were stained for
5-FUrd incorporation using anti-BrdU antibodies. Nuclear DNA was stained with DAPI. Representative immunoﬂuorescence images are shown. Scale bar,
5 mM. (f). Quantiﬁcation of 5-FUrd staining shown in e, done as in Fig. 2e; P value (Wilcoxon test)¼ *4.84 10 11, **6.12 10 12. Note the presence of
many outliers in samples transfected by KDM4A siRNA, which most likely correspond to untransfected cells. The median values are shown as horizontal
lines, outliers are shown as open circles; n¼ 3.
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that KDM4A is relocalized to the nucleoli in response to serum.
We next tested if KDM4A–rDNA association is also regulated by
serum using ChIP approach. We found that in starved cells
association of KDM4A with the rDNA promoter was nearly
abolished (Fig. 4b; Supplementary Fig. 3b). However, it was
restored as soon as 30min after serum addition at a level that
remained constant for 1 h. Importantly, such a serum-induced
recruitment of KDM4A is speciﬁc to rDNA, since on a
Pol-II-regulated target of KDM4A, the CDC6 promoter20,
binding of KDM4A was unchanged upon serum stimulation
(Fig. 4c; Supplementary Fig. 3c). Importantly, KDM4A
association with DNA is limited to the speciﬁc loci and
not detected at non-KDM4A dependent genes (Fig. 4c;
Supplementary Fig. 3c). Thus, the increase of KDM4A
occupancy at the rDNA is not a mere consequence of the
global increase in KDM4A level but reﬂects the functional
importance of the serum-dependent regulation of KDM4A
nucleolar localization.
Interestingly, and by contrast to what we observed in growing
cells (Fig. 1c), KDM4A was transiently recruited to the
transcribed region of rDNA following serum stimulation,
suggesting that KDM4A can have targets outside the promoter,
perhaps allowing the ﬁrst round of transcription. These results
are consistent with our ﬁnding of a physical interaction between
Pol-I and KDM4A (Fig. 1d), since Pol-I is present upon serum
addition on both the rDNA promoter and the coding region21
(Supplementary Fig. 6a).
Taken together, these data indicate that the nucleolar
localization of KDM4A and its association with rDNA
are controlled by growth factor-/nutrient-dependent
mechanisms.
KDM4A favours rDNA transcription by demethylating H3K9.
We next investigated the mechanism by which KDM4A
participates in rRNA synthesis upon serum stimulation. We ﬁrst
tested whether KDM4A enzymatic activity is required for the
regulation of Pol-I transcription by investigating the ability of
wild-type KDM4A or a KDM4A mutant (KDM4AH188A)
defective for histone demethylase activity15 to restore rDNA
transcription in cells depleted from endogenous KDM4A.
We transfected U2OS cells with siRNA targeting the
50 untranslated region of KDM4A (so that it did not silence
the expression of recombinant KDM4A which does not contain
the 50UTR), and we found, as expected, that this siRNA affect the
efﬁciency of activation of rDNA transcription (Fig. 5a, column
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Figure 4 | KDM4A localization and association with rDNA is controlled by serum. (a). U2OS cells were serum starved for 24 h (t¼0) and refed with
serum. Cells were ﬁxed at 30 and 60min following serum addition, and analysed by indirect immunoﬂuorescence using antibodies speciﬁc to human
KDM4A (Ab1 Bethyl Lab, panels 1) and human Pol-I largest subunit A194 (panels 2); nuclear DNA was stained by DAPI (panels 3). Merged images are
shown (panel 4). Scale bar, 5 mM. (b) ChIP assays were performed using antibodies speciﬁc to human KDM4A (Ab1, Bethyl Lab) and chromatin isolated
from starved and starved–refed cells (30 and 60min after serum addition) and analysed as in Fig. 1c to determine KDM4A binding to rDNA promoter (Pr),
transcribed region (TrR) or non-transcribed region (nTrR). The value of each bar represents the difference between the signals from the speciﬁc antibody
and from the negative control (an appropriate IgG) expressed as % from total chromatin input (see Supplementary Fig. 3b for raw data). Standard
deviations from three independent experiments are shown; n¼ 3. (c) ChIP assays were performed using antibodies speciﬁc to human KDM4A as in b and
chromatin immunoprecipitated from starved and starved–refed cells (60min after serum addition) were analysed by qPCR for the presence either CDC6 or
P0 or GAPDH promoters representing a positive and negative controls of the anti-KDM4A ChIP, respectively. The value of each bar represents the
difference between the signals from the speciﬁc antibody and from the negative control (an appropriate IgG) expressed as % from total chromatin input
(see Supplementary Fig. 3c for raw data). Standard deviations from three independent experiments are shown; n¼ 3.
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2 and b). Strikingly, overexpression of wild-type KDM4A before
starvation and refeeding, but not of the enzymatic-defective
KDM4A, efﬁciently restored rDNA transcription (Fig. 5a,b; see
Supplementary Fig. 8a for KDM4A expression). Moreover, in the
absence of siRNA depletion of KDM4A, we observed that cells
expressing inactive KDM4A exhibited decreased levels of rDNA
transcription compared with wild type showing its dominant-
negative effect (Supplementary Fig. 8b,c).
These results indicate that KDM4A demethylase activity is
required for efﬁcient activation of rRNA synthesis and that the
inactive KDM4A functions as a dominant-negative mutant,
suggesting the importance of changes in the methylation status
of KDM4A substrates at rDNA genes.
The human genome contains 4300 copies of rDNA repeats
and the chromatin structure of these repeats is not uniform,
rDNA genes being either hetero- or euchromatic19,22. Our ChIP
data showed that KDM4A is associated with rDNA and this
association is regulated by serum (Fig. 1c; Fig. 4b). However,
these experiments do not allow to distinguish heterochromatic
and euchromatic rDNA. Thus, we next investigated whether
KDM4A associated with a particular subpopulation of rDNA
genes. To this goal, we ﬁrst isolated rDNA associated with Pol-I,
corresponding to euchromatic rDNA, by immunoprecipitating
chromatin with antibodies speciﬁc to the core Pol-I subunit
(second largest subunit A135). Indeed, according to previous
results21 and our data (Supplementary Fig. 6a), a signiﬁcant
fraction of Pol-I remains associated with rDNA promoter and
transcribed regions in serum-starved cells which allows isolation
of euchromatic rDNA.
This result stands in contrast to a previous report, which
showed that Pol-I is mainly associated with the transcriptionally
active pool of rDNA, and that its association is lost in starved
cells8. In our hands, association of Pol-I with rDNA in various
cell lines (U2OS, HeLa and MCF7) is only lost if the cells are
under severe stress (that is, at least 48 h of serum deprivation)
which is accompanied by changes in nucleolar morphology and
by a signiﬁcant decrease in cell viability (K.I.P., unpublished
data). Therefore, the most likely explanation for this discrepancy
is the different sensitivity of various cells to metabolic stresses
and/or differences in starvation regime.
The Pol-I-associated chromatin was next subjected to a second
round of immunoprecipitation using antibodies speciﬁc to
KDM4A as well as non-modiﬁed or modiﬁed histones. Using
this sequential ChIP (sChIP) approach we detected a signiﬁcant
signal of rDNA promoter regions following KDM4A sChIP,
conﬁrming that KDM4A associates with the euchromatic pool of
rDNA repeats (Fig. 6a; Supplementary Fig. 3d).
We next investigated the dynamic of H3K9 methylation marks
at the Pol-I-bound rDNA using sChIP approach in normal and
KDM4A-depleted cells. Since histone H3 occupancy at the rDNA
gene changed during activation (Supplementary Fig. 6b–d),
signals obtained for methylated H3K9 marks were normalized
to total H3 signal. No speciﬁc signal could be observed for
H3K9me2 at rDNA loci (Supplementary Fig. 9b,e). However, we
found that the level of H3K9me3 occupancy at the transcription-
ally competent rDNA decreased upon serum refeeding whereas
H3K9me1 occupancy increased (Fig. 6b,c), correlating spatially
and temporally with the association of KDM4A with rDNA
(Fig. 6a). Importantly, siRNA-mediated depletion of KDM4A
prevented these changes (Fig. 6d,e; see also Supplementary Fig. 9
for non-normalized raw ChIP data). We were unable to detect
any enrichment in H3K36me3 (another known substrate of
KDM4A) at euchromatic rDNA (Supplementary Fig. 10).
Taken together, these results suggest that KDM4A speciﬁcally
demethylates trimethylated H3K9 at the promoter and the
transcribed regions of active rDNA repeats upon refeeding of
starved cells and this demethylation plays an important role in
the serum-mediated activation of rDNA transcription.
PI3K pathway controls nucleolar recruitment of KDM4A.
PI3K, MAPK and mTOR pathways are three main pathways
involved in the regulation of rDNA transcription in response to
environmental cues5,6. We thus intended to characterize the role
of these pathways in the control of KDM4A nucleolar
localization. We treated cells with speciﬁc inhibitors of these
kinases before serum stimulation and examined cellular
localization of KDM4A and level of nascent rRNA synthesis
(by 5-FUrd incorporation). The efﬁciency of inhibitors for their
capacity to block phosphorylation of speciﬁc downstream targets
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Figure 5 | KDM4A activity is important for serum-induced rRNA synthesis. (a) U2OS cells were electroporated with an expression vector encoding
either wild-type HA-tagged KDM4A (WT) or catalytically inactive mutant (MUT) or with empty vector (vector) together with a siRNA targeting the 50UTR
of KDM4A, to knockdown endogenous KDM4A while allowing expression of exogenous KDM4A proteins. Cells were grown for 24 h and then starved for
another 24 h before serum refeeding in the presence of 5-FUrd. 30min after serum addition cells were ﬁxed and analysed by indirect immunoﬂuorescence
using antibodies speciﬁc to HA-tag to detect overexpressed proteins, (panels 1), 5-FUrd (panels 2); nuclear DNA was stained by DAPI (panels 3). Merged
images are shown (panels 4). Bar¼ 5 mM. (b) Quantiﬁcation of 5-FUrd staining shown in a, done as in Fig. 2e. Note that the 5-FUrd levels of the cell
populations overexpressing the MUT and the WT are signiﬁcantly different (P value¼4.97 10 9, Wilcoxon test). The median values are shown as
horizontal lines, outliers are shown as open circles; n¼ 3.
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was controlled by western blot (Supplementary Fig. 11). As
expected we found that all inhibitors affected 5-FUrd
incorporation and therefore rRNA synthesis at various levels
(Fig. 7a,b, column 2, and c). However, only the PI3K inhibitors
(LY29002 and PI-103), but not MEK/MAPKK (PD98059) or
mTOR (Rapamycin) inhibitors, prevented the accumulation of
KDM4A in the nucleolus upon serum addition (Fig. 7a,b,
column 1; see Supplementary Fig. 11 for the effects of these
inhibitors in serum deprived cells). Importantly, overexpression
of wild-type PTEN, a PI3P phosphatase and as such a speciﬁc
inhibitor of the PI3K pathway also blocked KDM4A
relocalization to the nucleolus in response to serum (Fig. 7d),
further demonstrating the involvement of the PI3K pathway in
this subnuclear distribution of KDM4A.
The inhibition of MAPK or mTOR pathways affects 5-FUrd
incorporation and therefore rDNA transcription to a lesser
extent than the inhibition of PI3K pathway (Fig. 7a, column 2
and c). Thus, the loss of KDM4A localization followed by
PI3K inhibition could be an indirect effect of severe repression
of Pol-I transcription. To rule out this hypothesis, we combined
the inhibition of the MAPK and mTOR pathways, which
are known to cooperate in the serum-induced activation of
rDNA transcription23. Such a treatment led to a blockage
of rRNA production nearly as efﬁcient as inhibition of
PI3K pathway (Fig. 7a, column 2 and c). Nevertheless, it still
had no effect on KDM4A localization (Fig. 7a, column 1). Thus,
PI3K is the master regulator of KDM4A recruitment to the
nucleoli.
Since we showed that KDM4A protein levels increase upon
serum refeeding, we tested if PI3K, mTOR and MAPK pathway
can regulate the stability of KDM4A. Our results, shown in
Supplementary Fig. 5d,e, strongly suggest that it is not the case.
Importantly, we found that PI3K inhibition does not affect
serum-mediated induction of KDM4A expression levels (or its
stability, see Supplementary Fig. 5d,e) while drastically inhibiting
its nucleolar localization (Fig. 7), implying that nucleolar
localization of KDM4A and its stabilization are independent
serum-induced events.
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Figure 6 | KDM4A is important for serum-induced histone demethylation at rDNA repeats. (a) Chromatin was isolated from starved and starved–refed
cells (30min after serum addition) and subjected for the ﬁrst round of immunoprecipitation using antibody speciﬁc to Pol-I subunit A135. After elution
chromatin was subjected to the second IP round using antibody speciﬁc to KDM4A and analysed by qPCR as in Fig. 1c. The value of each bar represents the
difference between the signals from the speciﬁc antibody and from the negative control (an appropriate IgG) expressed as % from total chromatin input
(see Supplementary Fig. 3d for raw data). Standard deviations from three independent experiments are shown; n¼ 3. (b,c) Chromatin was isolated from
starved (b) and starved–refed U2OS cells (1 h after serum addition) (c) and the same quantities of a chromatin were subjected for the ﬁrst round of
immunoprecipitation using antibody speciﬁc to Pol-I subunit A135. After elution, the chromatin was subjected for the second IP round using antibodies
speciﬁc to histone H3, H3K9me1, H3K9me2 and H3K9me3 and analysed by qPCR as in Fig. 1c. The value of each bar represents the difference between the
signals from the speciﬁc antibody and from the negative control (an appropriate IgG) normalized to the speciﬁc H3 signal (representing the difference
between the signals from H3 speciﬁc antibody and an appropriate IgG, see Supplementary Fig. 6d for raw data) and expressed as % from total chromatin
input. Standard deviations from three independent experiments are shown (see Supplementary Fig. 9a-c for raw data); n¼ 3. (d,e). U2OS cells were
transfected with KDM4A speciﬁc siRNA3. 24 h post-transfection cells were starved for 24 h. Chromatin was isolated from starved (d) and starved–refed
cells (1 h after serum addition) (e). Chromatin was analysed as in b and c (see Supplementary Fig. 9d-f for raw data); n¼ 3.
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Strikingly, control of KDM4A localization is independent on
the classical PI3K–Akt pathway, since inhibition of Akt, a kinase
activated by PI3K phospholipids products did not impede
KDM4A relocalization to the nucleoli in response to serum
(Fig. 7b, column 1), despite having a major inhibitory effect on
rDNA transcription (Fig. 7b, column 2).
We thus investigated kinases downstream of PI3K, which could
be important for KDM4A relocalization. One attractive
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Figure 7 | PI3K pathway controls nucleolar localization of KDM4A. (a) U2OS cells were serum starved for 24 h. Starved cells were incubated for 30min
with MAPK inhibitor PD98059 (PD), mTOR inhibitor rapamycin (Rapa), or PI3K inhibitor LY294002 (LY) or a mixture of mTOR and MAPK inhibitors
(PDþ Rapa) or DMSO as a control (Untr) and refed with serum in the presence of 5-FUrd and the respective inhibitors. Thirty minutes after serum addition
cells were ﬁxed and analysed by indirect immunoﬂuorescence using antibodies speciﬁc to human KDM4A (Ab1, panels 1) and 5-FUrd (panels 2); nuclear
DNA was stained by DAPI (panels 3). Scale bar, 5 mM. (b) U2OS cells were serum starved for 24 h. Starved cells were incubated for 30min with PI3K
inhibitor PI-103, AKT inhibitor AKTVIII (AKT-i), or DMSO (Untr) and refed with serum in the presence of 5-FUrd and the respective inhibitors. Thirty
minutes after serum addition cells were ﬁxed and analysed by indirect immunoﬂuorescence using antibodies speciﬁc to human KDM4A (Ab1, panels 1) and
5-FUrd (panels 2); nuclear DNA was stained by DAPI (panels 3). (c) Quantiﬁcation of 5-FUrd staining shown in a and b done as in Fig. 2e. The effect of
inhibitors or combination of inhibitors are all signiﬁcant (P valueo104, Wilcoxon test), except treatment with PD alone. Note that no incorporation could be
measured upon AKT inhibition. The median values are shown as horizontal lines, outliers are shown as open circles; n¼ 3. (d) U2OS cells were transfected
with an expression vector encoding c-myc-tagged PTEN either wild-type (PTEN-WT) or mutated for its lipid phosphatase activity (PTEN-m). 24 h following
transfection, cells were serum starved for 24 h and refed with serum containing 5-FUrd. Cells were ﬁxed and analysed by indirect immunoﬂuorescence
using antibodies speciﬁc to c-myc Tag to detect overexpressed PTEN (panels 1); KDM4A (panels 2); nuclear DNA was stained by DAPI (panels 3).
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hypothesis was the involvement of the SGK1 kinase, known to
regulate biological activities in a manner similar to Akt, and
activated like Akt by PDK1, the major downstream effector
kinase of PI3K24. Indeed, chemical inhibition of PDK1, as well as
SGK1 (ref. 25) efﬁciently blocked KDM4A accumulation in the
nucleolus co-stained for the presence of Pol-I (Fig. 8a,b,
columns 1, see Supplementary Fig. 11a–d for western blots
monitoring the efﬁciency of these inhibitors). Pol-I staining
show that the integrity of nucleoli is preserved in inhibitor-treated
cells. To conﬁrm the involvement of SGK1 kinase, we inhibited its
expression using two independent siRNAs (see Supplementary
Fig. 11e for their validation), and we found that these two
siRNAs efﬁciently blocked KDM4A nucleolar accumulation
(Fig. 8c, column 1). Importantly, these inhibitors and siRNAs
also blocked rDNA transcription as shown by 5-FUrd
incorporation (Supplementary Fig. 7). We have summarized
effect of inhibition/depletion of all investigated kinases on
serum-driven activation of rRNA synthesis and relocalization of
KDM4A in Table 1.
In summary, our results indicate that KDM4A accumulation in
the nucleolus in response to serum stimulation is regulated by the
PI3K–SGK1 signalling cascade, participating in the activation of
rRNA synthesis.
Discussion
Here, we present evidence that KDM4A is important for
sustained activation of rDNA transcription in response to serum,
since (i) depletion of KDM4A by speciﬁc siRNAs leads to the
decrease of serum-stimulated rRNA synthesis observed both at
the cell population levels and in individual cells (Fig. 3); (ii) this
effect is complemented by the expression of siRNA-insensitive
recombinant KDM4A (Fig. 5); and (iii) KDM4A is recruited to
the rDNA during transcriptional activation (Figs 4 and 6).
Notably, KDM4A is not essential for rDNA transcription:
quantitative experiments relying on metabolic labelling indicate
that KDM4A depletion resulted in a two- to threefold decrease in
serum-induced rDNA transcription (Fig. 3). Moreover,
serum-starved cells readily transcribe rDNA despite we did not
ﬁnd any evidence for KDM4A presence at the rDNA promoter
(Fig. 4b). Furthermore, depletion of KDM4A from normally
growing cells has no major effect of rDNA transcription level
(Fig. 2). Thus, these data imply that KDM4A is required for
efﬁcient activation of rDNA transcription when cells have to
recover a full level of rRNA production after experiencing
unfavourable growth conditions (starvation in our case).
However, this role is still very important, since even 50%
reduction in rDNA transcription would have a signiﬁcant impact
on the capacity of cells to grow and divide (we have preliminary
evidence from several approaches to suggest thatB50% decrease
in Pol-I transcription can slow cell proliferation up to six-
to sevenfold). Furthermore, it has been demonstrated that
maintenance of elevated levels of Pol-I activity in cancer cells
appears critically important for the process of malignant
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Figure 8 | PI3K/SGK1 signalling cascade controls nucleolar localization
of KDM4A. (a) U2OS cells were serum starved for 24 h. Starved cells were
incubated for 30min with PDK1 inhibitor GSK2334470 (PDK1i), or PI3K
inhibitor LY294002 (LY) or DMSO as a control (Untr) and refed with serum
in the presence of 5-FUrd and the respective inhibitors (þ serum) or left
starved (no serum). Thirty minutes after serum addition cells were ﬁxed
and analysed by indirect immunoﬂuorescence using antibodies speciﬁc to
human KDM4A (panels 1) and Pol-I (panels 2); nuclear DNA was stained
by DAPI (panels 3). Scale bar, 5 mM. (b) U2OS cells were serum starved for
24 h. Starved cells were incubated for 30min with SGK1 inhibitor
GSK650394 (SGK1i), or DMSO as a control (Untr) and refed with serum in
the presence of 5-FUrd and inhibitor (þ serum) or left starved (no serum).
Thirty minutes after serum addition cells were ﬁxed and analysed by
indirect immunoﬂuorescence using antibodies speciﬁc to human KDM4A
(panels 1) and Pol-I (panels 2); nuclear DNA was stained by DAPI (panels
3). Scale bar, 5mM. (c) U2OS cells were electroporated with either a non-
targeting siRNA (siScr) or two siRNAs directed against SGK1 (siSGK1-1 and
siSGK1-2) and kept in serum-free medium for further 24 h before serum
refeeding in the presence of 5-FUrd. Thirty minutes after serum addition,
cells were ﬁxed and analysed by indirect immunoﬂuorescence using
antibodies speciﬁc to human KDM4A (panels 1) and Pol-I (panels 2);
nuclear DNA was stained by DAPI (panels 3). Scale bar, 5mM.
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transformation and cancer cell survival, as for example, a B35%
reduction in Pol-I transcription in Em-Myc lymphoma cells
resulted in induction of apoptosis as a consequence of immediate
nucleolar stress, even before ribosome insufﬁciency takes effect on
biosynthetic capacity26.
Our data also bring important insights into the precise step of
rDNA transcription which requires KDM4A. Recent studies have
revealed that in mammals, rDNA chromatin exists in three
different epigenetic states7,8,14.
– Firstly, silent, heterochromatic rDNA repeats which are
characterized by high level of DNA methylation and repressive
histone marks (40–60% of all repeats in cancer cells).
– Secondly, poised, transcriptionally competent, euchromatic
rDNA which is largely unmethylated and marked by hypoace-
tylated H3 and H4. The euchromatic poised rDNA genes
harbour the bivalent marks H3K4me3 and H3K27me3, as well
as trimethylated H3K9 (8,14 and this work). The so-called
bivalent promoters are characteristic of genes that have to be
quickly responsive to environmental cues, and have been ﬁrst
described for key development genes transcribed by Pol-II
(ref. 27). Interestingly, Pol-I is present at poised rDNA repeats
prior stimulation upon environmental changes (21 and our data).
– Thirdly, active, transcribed euchromatic rDNA which is also
unmethylated and characterized by higher levels of H3 and H4
acetylation combined with euchromatic histone marks.
The ratio between heterochromatic and euchromatic repeats
does not change during the cell cycle or in response to
environmental stimuli10,28, but can be altered during
development or malignant transformation19. In contrast, the
ratio between poised and transcribed rDNA repeats is regulated
through epigenetic-based mechanisms allowing the adaptation of
rDNA transcription during the cell cycle or in response to
metabolic and environmental conditions (serum starvation/
refeeding in this study). Therefore, unfavourable growth
conditions lead to accumulation of poised rDNA repeats which
are converted to their active form when conditions become more
favourable. The molecular mechanisms that drive this conversion
are not completely deﬁned and this work identify KDM4A as an
enzyme which is potentially involved in the initial stages of
chromatin ‘activation’.
This transition indeed requires conversion of H3K9me3 to
H3K9Ac. Here we propose that initial stage of this conversion is
controlled by KDM4A which is recruited to rDNA shortly after
refeeding (Figs. 4b and 6a). KDM4A targets H3K9me3 (a known
substrate of this enzyme) at the rDNA promoter, allowing its
demethylation and activation of rDNA transcription. The amount
of H3K9me1 is inversely correlated to H3K9me3 upon KDM4A
inhibition, suggesting that KDM4A speciﬁcally targets H3K9me3,
converting it to H3K9me1.
However, further conversion to unmethylated H3K9, allowing
its acetylation, must take place. Strikingly, it has been shown
that the histone demethylase PHF8/JHDM1F associates with
transcribed rDNA and positively regulates transcription by
targeting H3K9me2/1 (refs 29,30). We propose that KDM4A, at
the initial stage of activation, removes H3K9me3 mark converting
it to mono- or di-methylated K9, which can serve as substrates for
PHF8, then allowing its acetylation and maximal activation of
rDNA genes. In agreement with such a dynamic action of
KDM4A and PHF8, both KDM4A and PHF8 bind to H3K4me3,
the histone mark speciﬁc for active rDNA promoters29,31, which
may explain stable association of both enzymes with the promoter
and only transient association of KMD4A with transcribed region
of rDNA upon refeeding (Fig. 4b).
Notably, our data suggest that KDM4A, although important,
does not account for full transcriptional activation of rDNA in
response to serum. Indeed, depletion of KDM4A seems to have
more effect on H3K9me3 to H3K9me1 conversion (Fig. 6), than
on rRNA transcription (between two- and threefold) (Fig. 3).
One possible explanation is that only a subset of rDNA repeats is
regulated by H3K9 methylation and KDM4A, whereas others
escape such regulation. The presence of signiﬁcant level of basal
rRNA transcription in starved cells and our data on steady-state
level of transcription (Fig. 2) support this explanation.
An alternative, but not mutually exclusive hypothesis could
be that compensatory mechanisms are capable to induce a
hyper-activation of the small fraction of rDNA repeats that have
lost H3K9me3 in KDM4A-depleted cells.
Finally, we can conclude that at euchromatic rDNA, we
observe a dynamic picture of ever-changing histone modiﬁcations
which play an essential role in the ﬂexibility of transcriptional
regulation but the full complexity of which is still not entirely
understood.
Another exiting ﬁnding of this study is the discovery of a link
between the control of the subcellular localization of an enzyme
involved in epigenetic control of transcription (KDM4A) and the
activity of a signalling cascade regulated by the availability of
nutrients and growth factors (PI3K).
Three major pathways (PI3K, mTOR and MAPK) are activated
in response to nutrients/growth factors and known to regulate
rDNA transcription6,32,33. PI3K is a prominent signalling cascade
involved in control of cell growth, proliferation and survival and
that is often upregulated in various cancers34. PI3K is known to
regulate Pol-I transcription alone or in conjunction with mTOR
and MAPK pathways6,23. Many signalling cascades including
PI3K pathway, have been shown to target chromatin-modifying
enzymes including histone demethylases, affecting either their
stability, localization or activity (for reviews see refs 35–37).
The question of how KMTs/KDMs are linked to signalling
pathways is challenging and only few examples have been
documented. KMTs/KDMs are targeted by signalling factors
inside the nucleus leading in changes in partner association,
targeting to chromatin and/or substrate speciﬁcity38,39. Here,
we found that the PI3K pathway (but not the mTOR or
MAPK pathways) controls KDM4A cellular localization and
therefore its recruitment to rDNA through its downstream
kinase SGK1. Indeed, inhibition of PI3K or SGK1 suppress
both KDM4A relocalization to nucleoli of refed cells and
activation of Pol-I transcription (Figs 7 and 8). Our data also
suggest the involvement of the PDK1 kinase, which links PI3K
Table 1 | Effect of the inhibition of various serum-activated
kinases on the activation of rDNA transcription and on the
nucleolar localization of KDM4A.
Inhibited
kinase
How inhibited rDNA
transcription
level
Nucleolar
accumulation of
KDM4A
None None þ þ
mTOR Rapamycin  þ
MEK/MAPK PD98059  /þ þ
mTORþMEK Rapamycinþ
PD98059
 þ
PI3K LY29002 PI-103
overexpression
of wt PTEN
 
PDK1 GSK2334470  
AKT AktVIII  þ
SGK1 GSK650394
siRNA
 
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and SGK1, accordingly to its described role in SGK1 activation,
downstream of PI3K24,40.
Our ﬁnding represents to our knowledge the ﬁrst example of the
regulation of the intranuclear partition of a KDM between the
nucleoplasm and the nucleolus, which is required to adapt rDNA
transcription, and consequently ribosome biogenesis, to the
availability of growth factors/nutrients. The PI3K signalling
pathway is known to regulate rDNA transcription by targeting
various components of Pol-I transcription machinery. In response
to serum/nutrients stimulation it regulates both TIF-1A/RRN3
stability and nucleolar localization through Akt-mediated
modulation of CK2 activity41. PI3K was also described to
directly phosphorylate UBF42 and regulate SL1 occupancy at the
promoter23. PTEN, a negative regulator of the PI3K pathway was
described to inhibit Pol-I transcription by disturbing the SL1
complex on rDNA, although the mechanism remains unclear43.
Our data add another mechanism for the regulation of rDNA
transcription by PI3K that takes place at the chromatin level
through the regulation of KDM4A by PI3K–SGK1 signalling
cascade. Hence, the distinct routes converge controlling the
activation of rDNA transcription (see model of the regulation of
rDNA by PI3K in Fig. 9).
What is the mechanism by which the PI3K–SGK1 cascade
favours nucleolar accumulation of KDM4A? Interestingly, we
found that serum treatment leads to increased stability of
KDM4A and consequently its accumulation (Supplementary
Fig. 5). However, this is unlikely to be linked to KDM4A
relocalization, since PI3K inhibition does not prevent the serum-
induced increase in KDM4A level (Supplementary Fig. 5) but
blocks its nucleolar shuttling (Fig. 7). Thus, the PI3K–SGK1
cascade regulates the afﬁnity of KDM4A for the nucleolus, most
probably by phosphorylating KDM4A (or its associated partner),
thus facilitating its nucleolar translocation (see our model in
Fig. 9). Interestingly, SGK1 inhibition/depletion has a very strong
impact on rRNA synthesis, which is comparable to the effect of
PI3K inhibition (Supplementary Fig. 7). This suggests that like
PI3K, SGK1 may potentially regulate Pol-I transcription by
targeting various components of Pol-I transcription apparatus.
Therefore, SGK1 may have a dual role in the regulation of
Pol-I transcription: (i) as shown here, it regulates KDM4A
cellular localization on serum-dependent manner affecting as
consequence rDNA chromatin structure and (ii) in addition, it
could target components of Pol-I transcription machinery either
directly or indirectly, thus further enhancing the rDNA
transcriptional activation. Clearly, further studies are required
to determine how exactly the PI3K/SGK1 axis regulates KDM4A
localization and Pol-I transcription.
In conclusion, here we propose a novel role of PI3K signalling
in the regulation of epigenetic changes at speciﬁc loci. PI3K acts
through SGK1 by regulating the subcellular localization of histone
demethylase KDM4A in response to serum. KDM4A moves
inside the nucleolus to target trimethylated H3K9, initiating
events leading to the activation of rDNA transcription.
Interestingly, strong links have been uncovered between
upregulation of Pol-I transcription or PI3K activity and cancer34
and now we have established that KDM4A is targeted by PI3K
pathway and controls activation of Pol-I transcription. Our
results thus extend a general role of KDM4A in the regulation of
protein synthesis and imply that KDM4A may be a very
promising target in anticancer therapy.
Methods
Cell culture conditions. U2OS cells were obtained from ATCC and maintained
according to the supplier’s instructions in McCoy’s 5A medium plus 10% FBS
(PAA). For serum starvation–refeeding experiments cell were grown to B60–70%
conﬂuency, washed twice with Dulbecco’s PBS and then serum-starved for 20–24 h
in DMEM low glucose (1 g l 1). For activation of Pol-I transcription, serum-
starved cells were incubated in DMEM low glucose (1 g l 1) containing 20% FBS
(Lonza). All media were supplemented with 100 U/ml penicillin and 100 mgml 1
streptomycin (Gibco) and cells were maintained in a 37 C incubator with 5% CO2.
Hela cells were obtained from ATCC and grown in DMEM containing 10% FBS.
GC32 cells were a gift from Bernard Lopez (Toulouse, France) and WI38 cells were
given by Estelle Nicolas (Toulouse, France).
The ﬁnal concentration of kinase inhibitors dissolved in DMSO was as
described elsewhere: PD98059 (25 mM); Rapamycin (50 nM); LY29002 (20mM);
PI-103 (5mM); AktVIII (2.5 or 5 mM); GSK2334470 (1 mM); GSK650394 (10 mM).
They were added to cells 1 h before refeeding and kept afterwards. Cycloheximide
(Sigma) was used at 100mM as previously described for the study of KDM4A
stability in U2OS cells.
Transfection. Wild-type human HA-tagged KDM4A CMV-driven expression
plasmid was a gift from J. Christensen. The demethylase-dead KDM4A mutant was
constructed by mutating H188 to A, directly in the WT plasmid using the quick
change mutagenesis kit following the manufacturer’s instructions (Agilent Tech-
nologies). siRNA were purchased from Eurogentec and are described in
Supplementary Table 3. For transfection, 106 U2OS cells were electroporated with
double-stranded siRNA to a ﬁnal concentration of 1 mM, separately or together
with 2 mg of plasmids by using an eletroporation device (Amaxa AG, Cologne,
Germany) according to the manufacturer’s speciﬁcations (Buffer V, X001
program). Expression plasmid encoding myc-tagged wild-type PTEN
(pcDNA3-PTENWT) was a gift from Evelyne Goillot (ENS Lyon, France). Cells
were seeded on glass coverslips and transfected with either empty pCDNA3,
pcDNA3-PTENwt or pcDNA3-PTENmut using jetPEI with a ratio of 1 mg DNA
for 2 ml of jetPEI following the manufacturer’s recommendation (Ozyme).
RNA labelling in cells and rRNA analysis. Labelling of RNA in cells (B70%
conﬂuent orB50% for starved/refed) and RNA analysis was performed essentially
as described44 using 10mCi 3H-uridine for B0.2–0.4 105 cells per well of a
six-well plate. RNA was extracted (Pure Link RNA Mini kit, Life Technologies).
2 mg of 3H-labelled total RNA was run on a 1% formaldehyde agarose gel at 120V
for 95min in 1 MOPS, blotted onto Hybond-N membrane (Amersham),
crosslinked (ultraviolet cross-linker; UVP), analysed by tritium imaging using Fuji
Tritium image plate (or following PerkinElmer En3Hance spray, exposed to Kodak
Biomax XAR ﬁlm at  80C) and then quantiﬁed using Aida software. The s.d. was
calculated from three independent experiments.
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Akt MAPK
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Figure 9 | Schematic outline of serum-induced pathways controlling
rDNA transcription. PI3K–Akt, mTOR and MAPK pathways regulate rRNA
gene transcription by targeting RNA Polymerase I machinery (as previously
published, see Discussion). PI3K–PDK1–SGK1 signalling cascade regulates
activation of rRNA gene transcription by controlling histone modiﬁcations
at rDNA loci through KDM4A localization. SGK1 may in addition target Pol-I
transcription machinery independently of KDM4A.
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In situ RNA labelling was performed using 5-Fluorouridine (5-FUrd, Sigma).
Cells were incubated with 1mM 5F-Urd for 30min before ﬁxation with 4%
paraformaldehyde in PBS, for 15min at 4 C. 5-FUrd incorporation was analysed
by immunoﬂuorescence using anti-BrdU antibodies (BU-33, Sigma). All the
staining procedure was performed at 4 C, in the presence of 0.4 Uml 1
RiboGuard RNAse inhibitor (Epicentre). Quantiﬁcation of ﬂuorescence levels was
done on B100–200 cells per slide using home-developed macros in Image J
software (National Institutes of Health) and analysed using the R open source
software R Core Team (2014), (http://www.R-project.org/).
ChIP and sChIP assays. Cells were grown until 70% conﬂuent, crosslinked with
formaldehyde (ﬁnal concentration 1%) for 10min and the cross-linking was
stopped by addition of glycine (ﬁnal concentration 0.125M) for 5min. Crosslinked
chromatin was shared using Biorupter (Diagenode) to 300-base-pair average size.
For single round ChIP, immunoprecipitation was carried out using chromatin
isolated from 1 106 cells, antibodies listed in Supplementary Table 1 or
appropriate control IgGs and 30 ml of Protein A/Protein G magnetic beads
(Life Technologies). For sChIP, ﬁrst round of immunoprecipitation was carried out
using chromatin isolated fromB7 106 cells, 200 mg RPA135 antibody and 200 ml
of Protein A/Protein G magnetic beads (Life Technologies). All antibodies used are
listed in Supplementary Table 1. Chromatin was eluted from beads using two steps
elution. Initially beads were incubated overnight at 4 C in 400 ml of re-ChIP
elution buffer (1% Triton X-100, 2mM EDTA, 150mM NaCl, 20mM Tris-HCl,
pH 8.1) containing 80 mg of RPA135 (N-17) P peptide (Santa Cruz). Next,
beads were resuspended in 100ml of 10mM DTT in re-ChIP elution buffer and
incubated 30min at 37 C. Eluates from both steps were pooled, and volume was
adjusted to 5ml by ChIP IP buffer (1% Triton X-100, 0.1% Sodium Deoxycholate,
0.1% SDS, 1mM EDTA, 125mM NaCl, 20mM Tris-HCl, pH 7.5). Second round
of immunoprecipitation was carried out using 1ml of chromatin from the ﬁrst
round (equivalent ofB1.4 106 cells), antibodies listed in Supplementary Table 1
or appropriate control IgGs and 30 ml of Protein A/Protein G magnetic beads
(Life Technologies). Puriﬁed immunoprecipitated DNA was analysed by two
tetraplex qPCR panels designed for 8 regions of the rDNA repeat; Promoter,
IGS4, 18S, 5.8S and 28S, Terminator, IGS1 and 50ETS (see Supplementary Table 2
for primers and probes sequences). Reactions were carried out on a LightCycler
480 with a reaction volume of 10 ml per well in triplicates. The speciﬁc signals
were calculated as the difference between the signals from the speciﬁc antibody
(that is, H3) and from the negative control (an appropriate IgG) and were
expressed as percentage of input chromatin. When mentioned the speciﬁc signals
of modiﬁed histone H3 were normalized to the speciﬁc H3 signals with the
standard deviation calculated from three independent ChIP experiments. Signal
representing the TrR is the average of the combined signal from 50ETS, 18S, 5.8S
and 28S rRNA. Signal representing the nTrR is the average of the combined signal
from IGS1 and IGS2.
Immunoﬂuorescence. Cells were ﬁxed with 4% paraformaldehyde and permeabi-
lized with 1% Triton X-100 in PBS or permeabilized 5min at 4 with 1% Triton
X-100 before ﬁxation with 4% paraformaldehyde as indicated in ﬁgure legends. Cells
were then incubated at 4 C overnight with the indicated primary antibodies: Rabbit
polyclonal anti-JMJD2A (Bethyl A-300-861-A; 0.5mgml 1), Rabbit polyclonal anti-
KDM4A antibodies (Sigma, HPA007610, 0.5mgml 1), Rabbit polyclonal anti-HA
(Cell Signaling C29F4, 1mgml 1), RPA 194 Santa Cruz SC-48385 1mgml 1,
mouse monoclonal anti-UBF (SC-13125 1mgml 1), mouse monoclonal anti-BrdU
2mgml 1 (BU-33, Sigma), mouse monoclonal anti-myc antibodies (9E10, Santa
Cruz). AlexaFluor-conjugated secondary antibodies were purchased from Fisher
Scientiﬁc. Observations were carried out with a ﬂuorescence microscope (DM5000;
Leica, Wetlar, Germany) equipped with a cooled charge-coupled device camera, and
images were acquired using the MetaMorph imaging system (Universal Imaging
Corp., West Chester, PA). For Z-stacks acquisition (Fig. 1b), images were collected
with a DM6000 Leica microscope equipped with semrock ﬁlters, a PiFoc piezofocus
device (Physic Instrumente), and a CollSnapHQ2 camera (Roper Scientiﬁc),
controlled by MetaMorph software (Universal imaging Corp.). Five Z-sections at
0.2mm spacing were projected onto a single plan.
Box-and-whisker plots of quantiﬁcation of 5-FUrd staining were obtained with
the R open source software R Core Team (2014), (http://www.R-project.org/).
They show the median, the 25 and 75% quantiles, as well as outliers (outliers
are identiﬁed by not being in the range [25%Quantile 1.5 InterQuantiles;
75%Quantileþ 1.5 InterQuantiles] where interQuantiles¼ 75%Quantile
 25%Quantile). These representations have to be accompanied by statistical
analysis of the comparison between the two populations. Statistical hypothesis tests
were applied to conﬁrm whether the hypothesis (that can be seen on the boxplot)
that there is a differences between indicators of the two populations (such as mean,
median, distribution) can be considered as true with a great conﬁdence or can be
due to random effect. Because data distribution was not normal (due to a threshold
applied during quantiﬁcation to remove background staining), we used a Wilcoxon
test to reject the hypothesis that the two populations means are the same and thus
conclude that there is a signiﬁcant difference between the two means if the P value
iso0.05, meaning a conﬁdence of 95%.
Immunoblotting and immunoprecipitation. For western blotting, cells were lysed
in NuPage Sample lysis Buffer supplemented with reducing agent (Invitrogen) and
heated for 5min at 85 C to denature proteins. Western blots were performed using
standard procedures and antibodies were used at the following concentrations:
rabbit anti-KDM4A 0.4 mgml 1 (Bethyl A-300-861-A), rabbit anti-RPA194
0.2 mgml 1 (Santa Cruz SC-48385), mouse anti-PAF53 0.25 mgml 1 (BD
Transduction Labs, # P95220), mouse anti-UBF 0.2 mgml 1 (Santa Cruz
SC-13125), mouse anti-a-tubulin 0.1 mgml 1 (T6199, Sigma), rabbit anti p70S6K
(Cell Signaling, #9202), rabbit anti-PhosphoS6K (Cell Signaling, #9205), anti-Akt
(Cell Signaling, #9272), anti-Phospho-Akt (Ser473) (Cell Signaling, #9271),
anti-Phospho-Erk1/2 (Cell Signaling, #9101), anti-NDRG1 (Cell Signaling, #9485);
anti-Phospho-NDRG1 (Cell Signaling, #5482), anti-SGK1 (Cell Signaling, #12103).
All Cell signaling Ab were diluted 1/1,000. Peroxidase-conjugated secondary
antibodies were purchased from Amersham.
For immunoprecipitation, 107 cells were resuspended in hypotonic buffer
(10mM Tris PH 7.4, 1mM MgCl2, 10mM KCl and 1mM DTT). After breaking
the cells with a Dounce B pestle, nuclei were spin down at 500 g for 10min and
lysed in IP buffer (10mM Tris pH 8, 0.4% NP40, 300mM NaCl, 10% glycerol,
1mM DTT, anti-protease (Roche), anti-phosphatase (Sigma) inhibitors). Lysates
were diluted using one volume of dilution buffer (10mM Tris pH 8, 5mM CaCl2, 2
U/ml RQ1 DNAse (Promega) and then incubated with rabbit anti-KDM4A
antibodies 1 mgml 1 (A-300-861-A, Bethyl) or rabbit anti-HA antibodies
1 mgml 1 (C29F4 Cell signaling) as a control, overnight at 4 C. Protein complexes
were pull-down using a mix 1:1 of Protein A coupled to agarose (Sigma):Protein
G coupled to sepharose (Sigma). Following several washes with IP buffer, beads
were eluted with NuPAGE sample lysis buffer (Invitrogen) and analysed by western
blot. All steps were performed at 4 C.
mRNA level analysis. Total RNA was extracted from cells by using the RNeasy
mini kit (Qiagen). Five hundred nanograms of RNA were reverse transcribed for
50min at 42 C in a 20ml reaction volume containing 0.5 mM dNTPs, 0.5 mg of
random primers, 10mM DTT, 1 AMV RT buffer, 40U of RNasin and 10U of
AMV Reverse Transcriptase (Promega). Samples were incubated for 15min at
70 C to stop the reaction. Samples were analysed by qPCR by using the primers
described in Supplementary Table 4 on a CFX96 real-time system device (Biorad)
using the Platinum SYBR Green qPCR SuperMix (Invitrogen).
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